Amikacin News and Research

RSS
Nektar completes enrollment in NKTR-102 BEACON trial in patients with metastatic breast cancer

Nektar completes enrollment in NKTR-102 BEACON trial in patients with metastatic breast cancer

Patient enrollment underway in Phase III trial program to evaluate amikacin inhalation solution

Patient enrollment underway in Phase III trial program to evaluate amikacin inhalation solution

Specific therapy may cut pneumonia mortality in HIV babies

Specific therapy may cut pneumonia mortality in HIV babies

New approach can design antibiotics that kill even 'superbugs'

New approach can design antibiotics that kill even 'superbugs'

Insmed initiates patient screening for ARIKACE phase 2 NTM lung disease trial

Insmed initiates patient screening for ARIKACE phase 2 NTM lung disease trial

Insmed fourth quarter revenues increase to $1.4 million

Insmed fourth quarter revenues increase to $1.4 million

Insmed third quarter revenues decrease to $0.4 million

Insmed third quarter revenues decrease to $0.4 million

Insmed second quarter revenues decrease to $1.0 million

Insmed second quarter revenues decrease to $1.0 million

Insmed receives FDA clinical hold order for ARIKACE phase 3 trials in CF and NTM

Insmed receives FDA clinical hold order for ARIKACE phase 3 trials in CF and NTM

Insmed first quarter revenues decrease to $1.6 million

Insmed first quarter revenues decrease to $1.6 million

FDA clears Insmed IND for ARIKACE Phase 3 clinical trial in nontuberculous mycobacteria lung infections

FDA clears Insmed IND for ARIKACE Phase 3 clinical trial in nontuberculous mycobacteria lung infections

Scientists find antibiotic-resistant bacteria in seven species of sharks and redfish

Scientists find antibiotic-resistant bacteria in seven species of sharks and redfish

Scientists awarded $3.9M grant to study how XDR-TB transmitted in rural South Africa

Scientists awarded $3.9M grant to study how XDR-TB transmitted in rural South Africa

USPTO issues composition of matter patent for Transave's ARIKACE

USPTO issues composition of matter patent for Transave's ARIKACE

WHO estimates 440 000 MDR-TB cases in 2008

WHO estimates 440 000 MDR-TB cases in 2008

Positive results from Transave's Phase II ARIKACE clinical trials

Positive results from Transave's Phase II ARIKACE clinical trials

Positive results from Transave's Phase II clinical trial of ARIKACE in non-CF bronchiectasis patients

Positive results from Transave's Phase II clinical trial of ARIKACE in non-CF bronchiectasis patients

Clinical data on CXA-101 to be presented at ICAAC

Clinical data on CXA-101 to be presented at ICAAC

Lancet Infectious Diseases examines spread of XDR-TB

Lancet Infectious Diseases examines spread of XDR-TB

XDR-TB declining in the U.S.

XDR-TB declining in the U.S.